Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Dec 12, 2019 3:13 AM EST Latest News December 11, 2019 Kite Submits Biologics License Application to U.S. Food and Drug Administration for Company’s Second CAR T Cell Therapy December 11, 2019 Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta® and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma December 9, 2019 Kite Presents Positive Results From Pivotal ZUMA-2 Trial in Relapsed or Refractory Mantle Cell Lymphoma View All Events Oct 24, 2019 at 4:30 PM EDT Third Quarter 2019 Gilead Sciences Earnings Conference Call Sep 10, 2019 at 10:00 AM EDT Gilead Sciences at the Morgan Stanley Global Healthcare Conference Jul 30, 2019 at 4:30 PM EDT Second Quarter 2019 Gilead Sciences Earnings Conference Call View All
